Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ashim Gupta

Showing results (121-130 of 129) with videos related to

Pageof 13
Sort By:
You have reached the last page of results.This site can display upto 129 results.
EC Psychology and Psychiatry|June 26, 2023
Futuristic Thinking about Engineering "Geneospirituality" to Help Prevent Relapse of Reward Deficiency Syndrome (RDS) BehaviorsKenneth Blum, Thomas McLaughlin, Abdalla Bowirrat, et al.
Journal of the Neurological Sciences|September 29, 2023
Dopaminergic dysfunction: Role for genetic & epigenetic testing in the new psychiatryKenneth Blum, J Wesson Ashford, Babak Kateb, et al.
Current Neuropharmacology|September 25, 2025
PGx-Based in silico Analyses Identifies the Interactive Role of Genes, Glucose Metabolism and Dopaminergic Dysfunctional Pathways with Chronic Cocaine use and MisuseAlireza Sharafshah, Panayotis K Thanos, Albert Pinhasov, et al.
INNOSC Theranostics & Pharmacological Sciences|May 20, 2024
Addressing cortex dysregulation in youth through brain health check coaching and prophylactic brain developmentKenneth Blum, Eric R Braverman, Mark S Gold, et al.
Journal of Personalized Medicine|March 26, 2025
Genetic and Regulatory Mechanisms of Comorbidity of Anxiety, Depression and ADHD: A GWAS Meta-Meta-Analysis Through the Lens of a System Biological and Pharmacogenomic Perspective in 18.5 M SubjectsKai-Uwe Lewandrowski, Kenneth Blum, Alireza Sharafshah, et al.
Open Journal of Immunology|November 7, 2024
The First Pilot Epigenetic Type Improvement of Neuropsychiatric Symptoms in a Polymorphic Dopamine D2 (-DRD2/ANKK (Taq1A)), OPRM1 (A/G), DRD3 (C/T), and MAOA (4R) Compromised Preadolescence Male with Putative PANDAS/CANS: Positive Clinical Outcome with Precision-Guided DNA Testing and Pro-Dopamine Regulation (KB220) and Antibacterial TherapiesKenneth Blum, Igor Elman, David Han, et al.
Gene & Protein in Disease|May 20, 2024
Identification of stress-induced epigenetic methylation onto dopamine D2 gene and neurological and behavioral consequencesKenneth Blum, Abdalla Bowirrat, David Baron, et al.
Pain Physician|February 6, 2019
Responsible, Safe, and Effective Use of Biologics in the Management of Low Back Pain: American Society of Interventional Pain Physicians (ASIPP) GuidelinesAnnu Navani, Laxmaiah Manchikanti, Sheri L Albers, et al.
Journal of Addiction Psychiatry|December 5, 2024
Solving the Global Opioid Crisis: Incorporating Genetic Addiction Risk Assessment with Personalized Dopaminergic Homeostatic Therapy and Awareness Integration TherapyFoojan Zeine, Nicole Jafari, David Baron, et al.
Pageof 13

Showing results (121-130 of 129) with videos related to

Sort By:
Pageof 13
You have reached the last page of results.This site can display upto 129 results.
EC Psychology and Psychiatry|June 26, 2023
Futuristic Thinking about Engineering "Geneospirituality" to Help Prevent Relapse of Reward Deficiency Syndrome (RDS) BehaviorsKenneth Blum, Thomas McLaughlin, Abdalla Bowirrat, et al.
Journal of the Neurological Sciences|September 29, 2023
Dopaminergic dysfunction: Role for genetic & epigenetic testing in the new psychiatryKenneth Blum, J Wesson Ashford, Babak Kateb, et al.
Current Neuropharmacology|September 25, 2025
PGx-Based in silico Analyses Identifies the Interactive Role of Genes, Glucose Metabolism and Dopaminergic Dysfunctional Pathways with Chronic Cocaine use and MisuseAlireza Sharafshah, Panayotis K Thanos, Albert Pinhasov, et al.
INNOSC Theranostics & Pharmacological Sciences|May 20, 2024
Addressing cortex dysregulation in youth through brain health check coaching and prophylactic brain developmentKenneth Blum, Eric R Braverman, Mark S Gold, et al.
Journal of Personalized Medicine|March 26, 2025
Genetic and Regulatory Mechanisms of Comorbidity of Anxiety, Depression and ADHD: A GWAS Meta-Meta-Analysis Through the Lens of a System Biological and Pharmacogenomic Perspective in 18.5 M SubjectsKai-Uwe Lewandrowski, Kenneth Blum, Alireza Sharafshah, et al.
Open Journal of Immunology|November 7, 2024
The First Pilot Epigenetic Type Improvement of Neuropsychiatric Symptoms in a Polymorphic Dopamine D2 (-DRD2/ANKK (Taq1A)), OPRM1 (A/G), DRD3 (C/T), and MAOA (4R) Compromised Preadolescence Male with Putative PANDAS/CANS: Positive Clinical Outcome with Precision-Guided DNA Testing and Pro-Dopamine Regulation (KB220) and Antibacterial TherapiesKenneth Blum, Igor Elman, David Han, et al.
Gene & Protein in Disease|May 20, 2024
Identification of stress-induced epigenetic methylation onto dopamine D2 gene and neurological and behavioral consequencesKenneth Blum, Abdalla Bowirrat, David Baron, et al.
Pain Physician|February 6, 2019
Responsible, Safe, and Effective Use of Biologics in the Management of Low Back Pain: American Society of Interventional Pain Physicians (ASIPP) GuidelinesAnnu Navani, Laxmaiah Manchikanti, Sheri L Albers, et al.
Journal of Addiction Psychiatry|December 5, 2024
Solving the Global Opioid Crisis: Incorporating Genetic Addiction Risk Assessment with Personalized Dopaminergic Homeostatic Therapy and Awareness Integration TherapyFoojan Zeine, Nicole Jafari, David Baron, et al.
Pageof 13